Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Oncology 22

Oncology

MedTech News for Laborie, Sirtex, Paige, Neurovalens

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Laborie Medical Acquired Urotronic; Sirtex’s LAVA Liquid Embolic System; Paige’s Cancer Detection in Breast Lymph Nodes; FDA Clearance to Neurovalens’s Non-Invasive Insomnia-Treating Device; Recor Medical’s Renal Denervation System; Pulsecare Medical’s nsPFA Clinical Trial Short-term Follow-up Results

Neurovalens Received US FDA Clearance for Non-Invasive Insomnia-Treating Device On October 30, 2023, Belfast, Northern Ireland-based Neurovalens announced the US Food and Drug Administration clearance for its Modius Sleep device meant for treating chronic insomnia. Modius has been designed to deliver non-invasive electrical stimulation to key areas of the brain and nervous system. The need for surgically implanted electrodes is eliminated via Modius. For 30 minutes before bed, the device delivers a small, safe electrical pulse to the head. It allows users to perform activities, like watching television or reading during this period. ...

Explore More...

Pharma News and Updates for Coherus, Keymed, Roche, Vicore, Cassiopea

Coherus Biosciences’ Toripalimab; Keymed’s CMG901; Biogen Alzheimer’s Drug Aduhelm; Vicore’s Digital Therapeutics Study; Cassiopea’s Acne Treatment Winlevi; Samsung Biologics Acquires Samsung Bioepis; Roche’s Giredestrant; Ashai Kasei Acquires Bionova

bispecific-antibodies

Rise In Bispecific Antibodies Utilization As Antibody Therapeutics

Top Most Expensive Drugs in the US Healthcare Market

Top 12 Most Expensive Drugs in the US Healthcare Market

Pharma News and Updates for GSK, BriaCell, Gilead, Lilly, Merck, Halozyme

GSK Acquires Sierra Oncology; BriaCell’s Targeted Breast Cancer Immunotherapy; Merck’s Tepmetko; Gilead’s Magrolimab for MDS and AML; Eli Lilly’s Retevmo; Merck’s Pneumococcal Vaccine; FDA Approves Bevacizumab Biosimilar; Halozyme to Acquire Antares Pharma

AACR 2022 KRAS

AACR 2022: Novartis shifting focus towards directly targeting KRASG12c after disappointment from SHP2 inhibitor, TNO155.

tigit immunotherapy

AACR 2022 updates, recent disappointment, deals and collaboration of TIGIT immunotherapies

MedTech News for Alcon, I-VASC, Paige, Truvic, and Alucent

Alcon’s Dry Eye Treatment Device; I-VASC Secures Series A Funding; Paige’s AI Medical Device Software; TRUVIC’s Prodigy Thrombectomy System; Alucent’s Natural Vascular Scaffolding Technology; Guardant Presents Data Supporting Efficacy of Blood Test in Detecting Multiple Cancers

Pharma News and Updates BioXcel, Eton, Gilead, Pfizer, Alembic, Telix

BioXcel’s Agitation Drug Igalmi; FDA Approves Cysteine Hydrochloride Injection; Gilead’s Trodelvy; Alembic Pharma’s Topical Anesthetic Cream; Pfizer Acquires ReViral; Telix Buys Lilly’s Failed Cancer Drug Lartruvo

Pharma News and Updates Precigen, Biogen, Cerevance, Sanofi, Clovis

Precigen’s PRGN-3006; Yescarta Approved as a First CAR T-cell Therapy for R/R LBCL; Biogen & Ionis’ BIIB078; Nobelpharma’s HYFTOR (sirolimus topical gel) 0.2%; Cerevance Parkinson’s Drug; Sanofi & Regeneron’s Dupixent; Clovis’s Rubraca for Ovarian Cancer; Immunocore Eye Cancer Cell Therapy Approval

LAG 3 - The Future of Cancer Immunotherapy

LAG 3: A Promising Next Generation Cancer Immunotherapy

MedTech News for Ypsomed Fresenius Kabi Sientra Synchron HLT

Ypsomed-CamDiab’s Collaboration; Vela Diagnostics’s NGS-Based Pan-Cancer Panels; Fresenius’s SMOFlipid Lipid Injectable Emulsion; Sientra Gained Regulatory Nod to Market Breast Implants; Synchron’s Endovascular BCI Stentrode Device; HLT’s TAVR Clinical Studies

Top Drugs Losing Patent Protection in 2022

Analyzing the Most Promising Drugs That Will Lose Patent in the US & EU in 2022

Pharma News and Updates for Sanofi ViiV Argenx Novartis UCB Kyowa

Sanofi’s Rare Disease Drug Xenpozyme’ Approval; FDA Approves Novartis’ Pluvicto; AstraZeneca’s Imfinzi Trial Result; FDA’s Green Signal to Argenx’ Vyvgart; ViiV Healthcare and J&J’s HIV Treatment Cabenuva; UCB’s FINTEPLA Approval; Cullinan’s Update for CLN-081; MEI Pharma & Kyowa’s Zandelisib Approval

Pharma News and Updates for BMS, Biogen, Merck, Moderna, and Takeda

Bristol Myers’ Opdivo combo Opdualag for Melanoma; Biogen’s Aduhelm; Marinus’ Ztalmy for CDKL-5 Deficiency Disorder; Merck’s Keytruda + Lynparza; Vitaris’s Breyna; Moderna’s Second COVID-19 Booster Shot; Takeda’s Exkivity; BMS’s First LAG-3 Checkpoint Inhibitor

Metastatic Castration-Sensitive Prostate Cancer (mCSPC) Market Trends Analysis

Exploring the Metastatic Castration-Sensitive Prostate Cancer Market Landscape

Potential of Cannabidiol (CBD) as a Treatment Substance

Can Cannabinoids be an Effective Medicinal Substance?

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly